Patient-reported outcomes (PRO) in the setting of relapsed myeloma: the influence of treatment strategies and genetic variants predict quality of life and pain experience.
Authors
Ahmedzai, SSnowden, J
Cox, A
Cairns, D
Williams, C
Hockaday, A
Cavenagh, J
Parrish, C
Yong, K
Cavet, James
Hunter, H
Bird, J
Ashcroft, J
Brown, J
Morris, C
Cook, G
Affiliation
Department of Oncology, University of Sheffield, SheffieldIssue Date
2015